» Articles » PMID: 22811918

The Janus Face of Lipids in Human Breast Cancer: How Polyunsaturated Fatty Acids Affect Tumor Cell Hallmarks

Overview
Publisher Wiley
Date 2012 Jul 20
PMID 22811918
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

For several years, lipids and especially n - 3 and n - 6 polyunsaturated fatty acids (PUFAs) receive much attention in human health. Epidemiological studies tend to correlate a PUFA-rich diet with a reduced incidence of cancer, including breast cancer. However, the molecular and cellular mechanisms supporting the effect of PUFAs in breast cancer cells remain relatively unknown. Here, we review some recent progress in understanding the impact that PUFA may have on breast cancer cell proliferation, apoptosis, migration, and invasion. While most of the results obtained with docosahexaenoic acid and/or eicosapentaenoic acid show a decrease of tumor cell proliferation and/or aggressivity, there is some evidence that other lipids, which accumulate in breast cancer tissues, such as arachidonic acid may have opposite effects. Finally, lipids and especially PUFAs appear as potential adjuvants to conventional cancer therapy.

Citing Articles

The healthy eating index may not be an appropriate indicator for assessing dietary quality in breast cancer survivors: results from NHANES 2005-2018.

Zheng H, Chen S, Huang L, Zhou X, Huang Q, Li X Front Nutr. 2025; 11():1519607.

PMID: 39807218 PMC: 11725467. DOI: 10.3389/fnut.2024.1519607.


The protumorigenic enzyme GPAT2 inhibits arachidonic acid-triggered apoptosis in breast cancer.

Ferremi F, Moscoso V, Montanaro M, Gonzalez-Baro M, Cattaneo E Lipids Health Dis. 2024; 23(1):391.

PMID: 39605002 PMC: 11600616. DOI: 10.1186/s12944-024-02344-1.


Obesity Control and Supplementary Nutraceuticals as Cofactors of Brain Plasticity in Multiple Sclerosis Populations.

Ciumarnean L, Sarb O, Draghici N, Salagean O, Milaciu M, Orasan O Int J Mol Sci. 2024; 25(20).

PMID: 39456690 PMC: 11507128. DOI: 10.3390/ijms252010909.


Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies.

Mecca M, Sichetti M, Giuseffi M, Giglio E, Sabato C, Sanseverino F Nutrients. 2024; 16(12).

PMID: 38931238 PMC: 11206589. DOI: 10.3390/nu16121883.


Contribution of n-3 Long-Chain Polyunsaturated Fatty Acids to the Prevention of Breast Cancer Risk Factors.

Fodil M, Blanckaert V, Ulmann L, Mimouni V, Chenais B Int J Environ Res Public Health. 2022; 19(13).

PMID: 35805595 PMC: 9265492. DOI: 10.3390/ijerph19137936.


References
1.
Siddiqui R, Harvey K, Stillwell W . Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids. 2008; 153(1):47-56. DOI: 10.1016/j.chemphyslip.2008.02.009. View

2.
Kang K, Wang P, Yamabe N, Fukui M, Jay T, Zhu B . Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One. 2010; 5(4):e10296. PMC: 2858652. DOI: 10.1371/journal.pone.0010296. View

3.
Calder P . Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol. 2011; 668 Suppl 1:S50-8. DOI: 10.1016/j.ejphar.2011.05.085. View

4.
van de Vijver M, He Y, Vant Veer L, Dai H, Hart A, Voskuil D . A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002; 347(25):1999-2009. DOI: 10.1056/NEJMoa021967. View

5.
Hammamieh R, Sumaida D, Zhang X, Das R, Jett M . Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer. 2007; 7:138. PMC: 1940258. DOI: 10.1186/1471-2407-7-138. View